Human MAF1 targets and represses active RNA polymerase III genes by preventing recruitment rather than inducing long-term transcriptional arrest

Genome Research

Volumn 26, Issue 5, 2016, Pages 624-634

  Orioli, Andrea ^a   Praz, Viviane ^a,b   Lhôte, Philippe ^a   Hernandez, Nouria ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED RNA POLYMERASE III; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR MAF; TRANSFER RNA; MAF1 PROTEIN, HUMAN; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; REPRESSOR PROTEIN; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ARTICLE; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; GENE REPRESSION; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; CELL LINE; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PHYSIOLOGY;

CELL LINE; HUMANS; MULTIPROTEIN COMPLEXES; REPRESSOR PROTEINS; RNA POLYMERASE III; TOR SERINE-THREONINE KINASES; TRANSCRIPTION, GENETIC;

EID: 84964928032     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.201400.115     Document Type: Article

References (63)

1. Adelman K, Lis JT. 2012. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nat Rev Genet 13: 720-731.
2. Bailey TL, Boden M, Buske FA, Frith M, Grant CE, Clementi L, Ren J, LiWW, Noble WS. 2009. MEME Suite: tools for motif discovery and searching. Nucleic Acids Res 37: W202-W208.
3. Beck M, Schmidt A, Malmstroem J, Claassen M, Ori A, Szymborska A, Herzog F, Rinner O, Ellenberg J, Aebersold R. 2011. The quantitative proteome of a human cell line. Mol Syst Biol 7: 1-8.
4. Boguta M, Graczyk D. 2011. RNA polymerase III under control: repression and de-repression. Trends Biochem Sci 36: 451-456.
5. Bonhoure N, Bounova G, Bernasconi D, Praz V, Lammers F, Canella D, Willis IM, Herr W, Hernandez N, Delorenzi M, et al. 2014. Quantifying ChIP-seq data: a spiking method providing an internal reference for sample-to-sample normalization. Genome Res 24: 1157-1168.
6. Bonhoure N, Byrnes A, Moir RD, Hodroj W, Preitner F, Praz V, Marcelin G, Chua SC, Martinez-Lopez N, Singh R, et al. 2015. Loss of the RNA polymerase III repressor MAF1 confers obesity resistance. Genes Dev 29: 934-947.
7. Čabart P, Lee J, Willis IM. 2008. Facilitated recycling protects human RNA polymerase III from repression by Maf1 in vitro. J Biol Chem 283: 36108-36117.
8. Canella D, Praz V, Reina JH, Cousin P, Hernandez N. 2010. Defining the RNA polymerase III transcriptome: genome-wide localization of the RNA polymerase III transcription machinery in human cells. Genome Res 20: 710-721.
9. Canella D, Bernasconi D, Gilardi F, LeMartelot G, Migliavacca E, Praz V, Cousin P, Delorenzi M, Hernandez N, Deplancke B, et al. 2012. A multiplicity of factors contributes to selective RNA polymerase III occupancy of a subset of RNA polymerase III genes in mouse liver. Genome Res 22: 666-680.
10. Chan PP, Lowe TM. 2009. GtRNAdb: a database of transfer RNA genes detected in genomic sequence. Nucleic Acids Res 37: D93-D97.
11. Cooper SE, Hodimont E, Green CM. 2015. A fluorescent bimolecular complementation screen reveals MAF1, RNF7 and SETD3 as PCNA-associated proteins in human cells. Cell Cycle 14: 2509-2519.
12. Core L, Waterfall J, Lis J. 2008. Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science 322: 1845-1848.
13. Danko CG, Hah N, Luo X, Martins AL, Core L, Lis JT, Siepel A, Kraus WL. 2013. Signaling pathways differentially affect RNA polymerase II initiation, pausing, and elongation rate in cells. Mol Cell 50: 212-222.
14. Desai N, Lee J, Upadhya R, Chu Y, Moir RD, Willis IM. 2005. Two steps in Maf1-dependent repression of transcription by RNA polymerase III. J Biol Chem 280: 6455-6462.
15. Gilljam KM, Feyzi E, Aas PA, Sousa MML, Müller R, Vågbø CB, Catterall TC, Liabakk NB, Slupphaug G, Drabløs F, et al. 2009. Identification of a novel, widespread, and functionally important PCNA-binding motif. J Cell Biol 186: 645-654.
16. Gingold H, Tehler D, Christoffersen NR, Nielsen MM, Asmar F, Kooistra SM, Christophersen NS, Christensen LL, Borre M, Sørensen KD, et al. 2014. A dual program for translation regulation in cellular proliferation and differentiation. Cell 158: 1281-1292.
17. Goodfellow SJ, Graham EL, Kantidakis T, Marshall L, Coppins BA, Oficjalska-Pham D, Gérard M, Lefebvre O, White RJ. 2008. Regulation of RNA polymerase III transcription by Maf1 in mammalian cells. J Mol Biol 378: 481-491.
18. Greil F, Moorman C, van Steensel B. 2006. DamID: mapping of in vivo protein- genome interactions using tethered DNA adenine methyltransferase. Methods Enzymol 410: 342-359.
19. Grewal SS. 2015. Whyshould cancer biologists care about tRNAs? tRNA synthesis, mRNA translation and the control of growth. Biochim Biophys Acta 1849: 898-907.
20. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA. 2007. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130: 77-88.
21. Harismendy O, Gendrel C-G, Soularue P, Gidrol X, Sentenac A, Werner M, Lefebvre O. 2003. Genome-wide location of yeast RNA polymerase III transcription machinery. EMBO J 22: 4738-4747.
22. Hawkins RD, Hon GC, Lee LK, Ngo Q, Lister R, Pelizzola M, Edsall LE, Kuan S, Luu Y, Klugman S, et al. 2010. Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell 6: 479-491.
23. Hong R, Chakravarti D. 2003. The human proliferating cell nuclear antigen regulates transcriptional coactivator p300 activity and promotes transcriptional repression. J Biol Chem 278: 44505-44513.
24. Horton JR, Liebert K, Bekes M, Jeltsch A, Cheng X. 2006. Structure and substrate recognition of the Escherichia coli DNA adenine methyltransferase. J Mol Biol 358: 559-570.
25. Johnson SS, Zhang C, Fromm J, Willis IM, Johnson DL. 2007. Mammalian Maf1 is a negative regulator of transcription by all three nuclear RNA polymerases. Mol Cell 26: 367-379.
26. Kenneth NS, Ramsbottom BA, Gomez-Roman N, Marshall L, Cole PA, White RJ. 2007. TRRAP and GCN5 are used by c-Myc to activate RNA polymerase III transcription. Proc Natl Acad Sci 104: 14917-14922.
27. Kulak NA, Pichler G, Paron I, Nagaraj N, Mann M. 2014. Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells. Nat Methods 11: 319-324.
28. Laplante M, Sabatini DM. 2013. Regulation of mTORC1 and its impact on gene expression at a glance. J Cell Sci 126: 1713-1719.
29. Lund E, Dahlberg J. 1992. Cyclic 2',3'-phosphates and nontemplated nucleotides at the 3' end of spliceosomal U6 small nuclear RNA's. Science 255: 327-330.
30. Luo SD, Shi GW, Baker BS. 2011. Direct targets of the D. melanogaster DSXF protein and the evolution of sexual development. Development 138: 2761-2771.
31. Marshall L, Rideout EJ, Grewal SS. 2012. Nutrient/TOR-dependent regulation of RNA polymerase III controls tissue and organismal growth in Drosophila. EMBO J 31: 1916-1930.
32. Martin M. 2011. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal 17: 10-12.
33. Mendoza MC, Er EE, Blenis J. 2011. The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem Sci 36: 320-328.
34. Michels AA, Robitaille AM, Buczynski-Ruchonnet D, Hodroj W, Reina JH, Hall MN, Hernandez N. 2010. mTORC1 directly phosphorylates and regulates human MAF1. Mol Cell Biol 30: 3749-3757.
35. Moir RD, Lee J, Haeusler RA, Desai N, Engelke DR, Willis IM. 2006. Protein kinase A regulates RNA polymerase III transcription through the nuclear localization of Maf1. Proc Natl Acad Sci 103: 15044-15049.
36. Moqtaderi Z, Wang J, Raha D, White RJ, Snyder M, Weng Z, Struhl K. 2010. Genomic binding profiles of functionally distinct RNA polymerase III transcription complexes in human cells. Nat Struct Mol Biol 17: 635-640.
37. Motorin Y, Muller S, Behm-Ansmant I, Branlant C. 2007. Identification of modified residues in RNAs by reverse transcription-based methods. Methods Enzymol 425: 21-53.
38. Oficjalska-Pham D, Harismendy O, Smagowicz WJ, Gonzalez de Peredo A, Boguta M, Sentenac A, Lefebvre O. 2006. General repression of RNA polymerase III transcription is triggered by protein phosphatase type 2Amediated dephosphorylation of Maf1. Mol Cell 22: 623-632.
39. Oler AJ, Alla RK, Roberts DN, Wong A, Hollenhorst PC, Chandler KJ, Cassiday PA, Nelson CA, Hagedorn CH, Graves BJ, et al. 2010. Human RNA polymerase III transcriptomes and relationships to Pol II promoter chromatin and enhancer-binding factors. Nat Struct Mol Biol 17: 620-628.
40. Orioli A, Pascali C, Pagano A, Teichmann M, Dieci G. 2012. RNA polymerase III transcription control elements: themes and variations. Gene 493: 185-194.
41. Palian BM, Rohira AD, Johnson SAS, He L, Zheng N, Dubeau L, Stiles BL, Johnson DL. 2014. Maf1 is a novel target of PTEN and PI3K signaling that negatively regulates oncogenesis and lipid metabolism. PLoS Genet 10: e1004789.
42. Pavon-Eternod M, Gomes S, Geslain R, Dai Q, Rosner MR, Pan T. 2009. tRNA over-expression in breast cancer and functional consequences. Nucleic Acids Res 37: 7268-7280.
43. Phizicky EM, Hopper AK. 2010. tRNA biology charges to the front. Genes Dev 24: 1832-1860.
44. Pluta K, Lefebvre O, Martin NC, Smagowicz J, Stanford DR, Ellis SR, Anita K, Sentenac A, Boguta M, Smagowicz WJ, et al. 2001. Maf1p, a negative effector of RNA polymerase III in Saccharomyces cerevisiae. Mol Cell Biol 21: 5031-5040.
45. Raha D, Wang Z, Moqtaderi Z, WuL, Zhong G, Gerstein M, Struhl K, Snyder M. 2010. Close association of RNA polymerase II and many transcription factors with Pol III genes. Proc Natl Acad Sci 107: 3639-3644.
46. Reina JH, Azzouz TN, Hernandez N. 2006. Maf1, a new player in the regulation of human RNA polymerase III transcription. PLoS One 1: e134.
47. Renaud M, Praz V, Vieu E, Florens L, Washburn MP, L'Hôte P, Hernandez N. 2014. Gene duplication and neofunctionalization: POLR3G and POLR3GL. Genome Res 24: 37-51.
48. Rideout EJ, Marshall L, Grewal SS. 2012. Drosophila RNA polymerase III repressor Maf1 controls body size and developmental timing by modulating tRNAi Met synthesis and systemic insulin signaling. Proc Natl Acad Sci 109: 1139-1144.
49. Roberts DN, Wilson B, Huff JT, Stewart AJ, Cairns BR. 2006. Dephosphorylation and genome-wide association of Maf1 with Pol III-transcribed genes during repression. Mol Cell 22: 633-644.
50. Rohira AD, Chen C-Y, Allen JR, Johnson DL. 2013. Covalent small ubiquitin- like modifier (SUMO) modification of Maf1 protein controls RNA polymerase III-dependent transcription repression. J Biol Chem 288: 19288-19295.
51. Rollins J, Veras I, Cabarcas S, Willis I, Schramm L. 2007. Human Maf1 negatively regulates RNA polymerase III transcription via the TFIIB family members Brf1 and Brf2. Int J Biol Sci 3: 292-302.
52. Schmitt BM, Rudolph KLM, Karagianni P, Fonseca NA, White RJ, Talianidis I, Odom DT, Marioni JC, Kutter C. 2014. High-resolution mapping of transcriptional dynamics across tissue development reveals a stable mRNA-tRNA interface. Genome Res 24: 1797-1807.
53. Shimobayashi M, Hall MN. 2014. Making new contacts: the mTOR network in metabolism and signalling crosstalk. Nat Rev Mol Cell Biol 15: 155-162.
54. Shor B, Wu J, Shakey Q, Toral-Barza L, Shi C, Follettie M, Yu K. 2010. Requirement of the mTOR kinase for the regulation of Maf1 phosphorylation and control of RNA polymerase III-dependent transcription in cancer cells. J Biol Chem 285: 15380-15392.
55. Smyth G. 2005. limma: linear models for microarray data. In Bioinformatics and computational biology solutions using R and Bioconductor (ed. Gentleman R, et al.), pp. 397-420. Springer, New York.
56. Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, Haugen E, Sheffield NC, Stergachis AB, Wang H, Vernot B, et al. 2012. The accessible chromatin landscape of the human genome. Nature 489: 75-82.
57. van Steensel B, Delrow J, Henikoff S. 2001. Chromatin profiling using targeted DNA adenine methyltransferase. Nat Genet 27: 304-308.
58. Vannini A, Ringel R, Kusser AG, Berninghausen O, Kassavetis GA, Cramer P. 2010. Molecular basis of RNA polymerase III transcription repression by Maf1. Cell 143: 59-70.
59. White RJ, Stott D, Rigby PW. 1989. Regulation of RNA polymerase III transcription in response to F9 embryonal carcinoma stem cell differentiation. Cell 59: 1081-1092.
60. Xiao R, Roman-Sanchez R, Moore DD. 2010. DamIP: a novel method to identify DNA binding sites in vivo. Nucl Recept Signal 8: e003.
61. Xiao R, Sun D, Ayers S, Xi Y, LiW, Baxter JD, Moore DD. 2012. Research resource: the estrogen receptor α cistrome defined by DamIP. Mol Endocrinol 26: 349-357.
62. Yip CK, Murata K, Walz T, Sabatini DM, Kang SA. 2010. Structure of the human mTOR complex I and its implications for rapamycin inhibition. Mol Cell 38: 768-774.
63. Zhou Y, Goodenbour JM, Godley LA, Wickrema A, Pan T. 2009. High levels of tRNA abundance and alteration of tRNA charging by bortezomib in multiple myeloma. Biochem Biophys Res Commun 385: 160-164.